We have collected information about Nanoparticle-Mediated Delivery Of Therapeutic Drugs for you. Follow the links to find out details on Nanoparticle-Mediated Delivery Of Therapeutic Drugs.
https://link.springer.com/article/10.1007%2Fs40290-015-0096-4
Nanoparticles offer a stable means to achieve targeted drug delivery to various cells and tissues. They have been investigated for drug delivery to different tumor tissues, to brain where the blood–brain barrier poses a significant problem in the delivery of effective therapeutic molecules, to ocular tissues and also for eliciting immune response via delivery of vaccines.Author: Nisha Ponnappan, Archana Chugh
https://www.researchgate.net/publication/275220787_Nanoparticle-Mediated_Delivery_of_Therapeutic_Drugs
Nanoparticle-Mediated Delivery of Therapeutic Drugs. Nanotechnology-based pharmaceutics is a fast emerging field in the diagnosis and therapy of a number of human diseases, including cancer. Nanoparticles offer a stable means to achieve targeted drug delivery to various cells and tissues.
https://www.sciencedirect.com/science/article/pii/S0914508717300928
Nanoparticle-mediated drug delivery systems Administration of drugs and other therapeutic agents has been the central strategy of contemporary medicine, based on the concept that a certain disease comprises diseased cells and their molecules within healthy organs and body.Author: Tetsuya Matoba, Jun ichiro Koga, Kaku Nakano, Kensuke Egashira, Hiroyuki Tsutsui
https://www.mdpi.com/2077-0383/6/5/48/htm
Drug-incorporated nanoparticles for local delivery might optimize the efficacy and minimize the side effects of drugs. A phase I investigator-initiated clinical trial to test the efficacy of PLGA nanoparticle-mediated delivery of pitavastatin (UMIN000014940) has been completed.Author: Kazufumi Nakamura, Hiromi Matsubara, Satoshi Akagi, Toshihiro Sarashina, Kentaro Ejiri, Norifumi Kaw...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662261/
These results offer a rationale for delivering drugs conjugated toalbumin nanoparticle to underlying tissue. In conclusion, albumin-conjugated nanoparticles of 20 nm in diameterare effectively internalized by caveolar, suggesting that the caveolae pathway is a novel approach to deliver therapeutic nanoparticles across blood-endothelial barrier.Author: Zhenjia Wang
https://www.tandfonline.com/doi/abs/10.1517/17425247.2013.798640
Mar 23, 2018 · Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics. Introduction: Micro RNAs (miRNA) are 21 – 23 nucleotides long and regulate the expression of coding genes by binding imperfectly with their 3′ UTR region. The miRNA profile is altered in pathological processes, making miRNAs good targets for drug therapy.Author: Muthunarayanan Muthiah, In-Kyu Park, Chong-Su Cho
http://web.ics.purdue.edu/~jfleary/nanomedicine_course_2011/Lecture_10%20Gene%20Delivery/References/Jin%20and%20Ye%20Biotechnol%20Prog%202007.pdf
Nanoparticle-Mediated Drug Delivery and Gene Therapy Sha Jin† and Kaiming Ye*,‡ DNA Resource Center and Biomedical Engineering Program, College of Engineering, University of Arkansas, Fayetteville, Arkansas 72701 Biomedical application of nanotechnology is a rapidly developing area that raises new prospect
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624329/
Thus, there is a need to improve the biodistribution of chemotherapeutics to tumor with minimum peripheral exposure and thereby minimize the systemic toxicity. Advent of nanoparticle-based drug delivery resulted in tumor selective delivery of drugs by enhanced permeability and retention (EPR) effect with reduced peripheral exposure.Author: Vaibhav Mundra, Wei Li, Ram I Mahato
https://www.sciencedirect.com/science/article/pii/S1773224717304513
Recent advances in nanoparticle-mediated drug delivery. ... controlled and sustained discharge of the drug both during the transportation and at the target site increasing drug's therapeutic efficacy and reducing side effects, ... Parameters affecting nanoparticle-mediated drug delivery 1.11.1. Particle size.Author: Bipul Kumar, Kanika Jalodia, Pradeep Kumar, Hemant K. Gautam
https://pubs.acs.org/doi/10.1021/acsnano.9b09263
Together, these findings demonstrate that NP-mediated co-delivery of Notch-1 antibodies and ABT-737 is a potent treatment strategy for TNBC that may improve patient outcomes with further development and implementation.Author: Danielle M. Valcourt, Megan N. Dang, Mackenzie A. Scully, Emily S. Day
Searching for Nanoparticle-Mediated Delivery Of Therapeutic Drugs?
You can just click the links above. The data is collected for you.
